Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.91
Delayed Data
As of 4:00pm ET
 -0.03 / -1.02%
Today’s Change
2.58
Today|||52-Week Range
5.68
-17.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues376.4M444.4M585.0M585.1M
 
 
 
 
 
Depreciation And Amortization946.0K5.6M----
 
 
 
 
Operating ExpensesGross Income--438.8M----
 
 
General Expenses24.5M29.8M34.9M36.1M
 
 
 
 
 
Total Operating Expenses25.5M35.4M34.9M36.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income350.9M409.0M550.1M549.0M
 
 
 
 
 
Extraordinary Credit0.000.000.006.5M
 
 
Extraordinary Charge0.000.00-6.1M-4.0M
 
 
 
Interest Expense On Debt29.0M24.9M39.2M27.1M
 
 
 
 
 
Other Expenses-1.5M-1.5M-3.8M5.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income327.1M401.9M501.3M530.1M
 
 
 
 
 
Income Taxes-115.5M-137.3M-179.0M-197.3M
 
 
 
 
 
Net Income211.7M264.5M322.2M332.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.7M139.8M158.2M163.4M
 
 
 
 
 
Shares To Calculate EPS Diluted146.4M159.3M173.1M163.6M
 
 
 
 
 
 
Earnings Per ShareEPS$1.45$1.66$1.86$2.03
 
 
 
 
 
EPS Diluted$1.45$1.66$1.86$2.03